The diagnosis of malignancy following a venous thromboembolic event - how high is the risk?

E. Crawford, H. Moudgil, T. Naicker, N. Ahmad, K. Srinivasan (Telford, United Kingdom)

Source: International Congress 2014 – Respiratory disease within hospital-based populations
Session: Respiratory disease within hospital-based populations
Session type: Thematic Poster Session
Number: 4115

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Crawford, H. Moudgil, T. Naicker, N. Ahmad, K. Srinivasan (Telford, United Kingdom). The diagnosis of malignancy following a venous thromboembolic event - how high is the risk?. Eur Respir J 2014; 44: Suppl. 58, 4115

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Recurrence patterns for venous thromboembolism - who is most at risk?
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014

Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Confirmed pulmonary tuberculosis leading to late diagnosis of lung cancer - Study case
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013


The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Long-term impact of developing a postoperative pulmonary complications after lung surgery
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015

Miliary disease of the lung: What is your diagnosis?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013


Therapeutic surgical resection of primary pulmonary artery sarcoma
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Indeterminate solitary pulmonary nodule: Surgical diagnosis and models for predicting malignancy
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Clinical characteristics of elderly patients with pulmonary embolism and risk factors for recurrence
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Latent tuberculosis infection and the risk of cancer: A nationwide population-based study
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

The association of lung cancer with active pulmonary tuberculosis.
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014

Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

LATE-BREAKING ABSTRACT: Cardio vascular disease and the risk of lung cancer, the HUNT study
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013


Evaluation of predictors of early and late mortality in 414 acute pulmonary embolism patients
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Evaluation of incidental lung cancer in hospitalized patients with non-respiratory disease
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


Treatment of pulmonary carcinoid: Are there new options?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014